Molecular basis of agonism and antagonism in the oestrogen receptor
暂无分享,去创建一个
Zbigniew Dauter | Z. Dauter | J. Gustafsson | R. Hubbard | A. Brzozowski | A. Pike | T. Bonn | O. Engström | L. Öhman | G. Greene | M. Carlquist | Jan-Åke Gustafsson | Tomas Bonn | Mats Carlquist | Andrzej M. Brzozowski | Ashley C. W. Pike | Roderick E. Hubbard | Owe Engström | Lars Öhman | Geoffrey L. Greene | L. Öhman
[1] M. Beato,et al. Interaction of steroid hormone receptors with the transcription initiation complex. , 1996, Endocrine reviews.
[2] J M Thornton,et al. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.
[3] B. Katzenellenbogen,et al. Different Residues of the Human Estrogen Receptor Are Involved in the Recognition of Structurally Diverse Estrogens and Antiestrogens* , 1997, The Journal of Biological Chemistry.
[4] D. Ciocca,et al. Estrogen receptors in human nontarget tissues: biological and clinical implications. , 1995, Endocrine reviews.
[5] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[6] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[7] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[8] E. Kalkhoven,et al. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors , 1997, Molecular and cellular biology.
[9] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[10] B. Katzenellenbogen,et al. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor. , 1993, Molecular endocrinology.
[11] H W Cole,et al. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene. , 1997, Journal of medicinal chemistry.
[12] J. Lees,et al. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.
[13] William Bourguet,et al. A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.
[14] M. Parker,et al. Interaction of proteins with transcriptionally active estrogen receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] William Bourguet,et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.
[16] C. Arnaud,et al. A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] S. Fawell,et al. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor , 1990, Cell.
[18] P. Chambon,et al. Differential ligand‐dependent interactions between the AF‐2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. , 1996, The EMBO journal.
[19] B. Katzenellenbogen,et al. Antiestrogens: Mechanisms and actions in target cells , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[20] John A. Katzenellenbogen,et al. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site , 1997, Steroids.
[21] M. Parker,et al. RIP-140 interacts with multiple nuclear receptors by means of two distinct sites , 1996, Molecular and cellular biology.
[22] Mary E. McGrath,et al. A structural role for hormone in the thyroid hormone receptor , 1995, Nature.
[23] B. O’Malley,et al. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.
[24] H. Witkowska,et al. Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid , 1996, Steroids.
[25] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.
[26] B. Katzenellenbogen,et al. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] B. Katzenellenbogen,et al. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. , 1996, Molecular endocrinology.
[28] P. Chambon,et al. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer , 1988, Cell.
[29] B. Katzenellenbogen,et al. Different Regions in Activation Function-1 of the Human Estrogen Receptor Required for Antiestrogen- and Estradiol-dependent Transcription Activation* , 1996, The Journal of Biological Chemistry.